Biologics in congenital ichthyosis: an incomplete fix
- PMID: 39657116
- DOI: 10.1093/bjd/ljae475
Biologics in congenital ichthyosis: an incomplete fix
Conflict of interest statement
Conflicts of interest: E.A.O.T. has been an investigator for Kamari Pharma and Palvella Therapeutics and acted as a consultant and participated in advisory boards for Kamari Pharma, Palvella Therapeutics and Azitra. She has also received research grants from Unilever, LEO Foundation and Kamari Pharma (all money to university/hospital) and participated in patient advisory for PC Project and the Ichthyosis Support Group.
Comment on
-
Biologics in congenital ichthyosis: are they effective?Br J Dermatol. 2025 Jan 24;192(2):327-334. doi: 10.1093/bjd/ljae420. Br J Dermatol. 2025. PMID: 39470394
Publication types
LinkOut - more resources
Full Text Sources